scholarly journals Diagnosis of inflammatory bowel disease in chronic hepatitis C patients treated with pegylated interferon and ribavirin: Coincidence or consequence?

2013 ◽  
Vol 7 (5) ◽  
pp. e194 ◽  
Author(s):  
Paulo Salgueiro ◽  
Paula Lago ◽  
Isabel Pedroto
Keyword(s):  
Inflammatory Bowel Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Bowel Disease ◽  
Pegylated Interferon ◽  
Inflammatory Bowel ◽  
Chronic Hepatitis C Patients

scholarly journals Chronic hepatitis C, inflammatory bowel disease and interferon therapy

2012 ◽  
Vol 6 (5) ◽  
pp. 626-627 ◽  
Author(s):  
Cumali Efe ◽  
Emir Charles Roach ◽  
Tugrul Purnak ◽  
Ersan Ozaslan
Keyword(s):  
Inflammatory Bowel Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Bowel Disease ◽  
Interferon Therapy ◽  
Inflammatory Bowel

scholarly journals Gastroenterology Cases of Cutaneous Leukocytoclastic Vasculitis

2013 ◽  
Vol 2013 ◽  
pp. 1-4
Author(s):  
Cumali Karatoprak ◽  
Elif Arabaci ◽  
Kemal Yildiz ◽  
Mustafa Cakirca ◽  
Mehmet Ali Cikrikcioglu ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Chronic Hepatitis ◽  
Crohn’S Disease ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Ischemic Colitis ◽  
Bowel Disease ◽  
Leukocytoclastic Vasculitis ◽  
Underlying Disease ◽  
Inflammatory Bowel

Rarely, leukocytoclastic vasculitis can result from ischemic colitis, inflammatory bowel disease, and cryoglobulinemia. There is no established standard for the treatment of leukocytoclastic vasculitis associated with gastroenterologic diseases. This paper presents three cases of leukoytoclastic vasculitis, each of which is associated with a different gastroenterologic condition: ischemic colitis, Crohn’s disease, and chronic hepatitis C. Each condition went into remission by treatment of leukocytoclastic vasculitis, regardless of the underlying disease.

AF.91 TRENDS OF LIVER STIFFNESS IN INFLAMMATORY BOWEL DISEASE WITH CHRONIC HEPATITIS C

2021 ◽  
Vol 53 ◽  
pp. S179
Author(s):  
G. Losurdo ◽  
A. Iannone ◽  
A. Contaldo ◽  
M. Barone ◽  
E. Ierardi ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Bowel Disease ◽  
Liver Stiffness ◽  
Inflammatory Bowel

Chronic viral hepatitis and inflammatory bowel disease

2021 ◽  
Vol 11 (2) ◽  
pp. 29-34
Author(s):  
G.V. Volynets ◽  
◽  
A.I. Khavkin ◽  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Hepatitis B ◽  
Viral Hepatitis ◽  
Immunosuppressive Therapy ◽  
Chronic Hepatitis C ◽  
Bowel Disease ◽  
Chronic Viral Hepatitis ◽  
Inflammatory Bowel

The article presents the results of a literature review devoted to the study of the problems of the combined course of inflammatory bowel diseases (IBD), which include ulcerative colitis (UC) and Crohn's disease (CD), and chronic viral hepatitis (CVH) – chronic hepatitis B (CHB) and chronic hepatitis C (CHC). The frequency of occurrence of CHB and CHC in IBD in different countries is presented, which ranges from 1 to 9%. The clinical course of these combined diseases, the possibility of reactivation of hepatitis B virus (HBV) and hepatitis C virus (HCV) during immunosuppressive therapy are described. Recommendations on the specifics of examination and management of patients with combined pathology of IBD and CVH are presented. Conclusion. The combined pathology of IBD and CVH is a significant public health problem around the world that requires further large-scale study. The use of immunosuppressive therapy for IBD can be accompanied by the activation of HBV and HCV infection, therefore, the management of such patients should be individualized. Key words: inflammatory bowel disease, chronic hepatitis B, chronic hepatitis C, immunosuppressive therapy

Sign in / Sign up

Export Citation Format

Share Document